Authors
Shevchenko Yu.L., Borshchev G.G., Miminoshvili L.G.
St. George thoracic and cardiovascular surgery clinic Pirogov National Medical and Surgical Center, Moscow
Abstract
Over the years, surgical treatment techniques for patients with coronary heart disease (CHD) have undergone changes. This literature review examines the relevance of surgical treatments, the history of the development of methods for stimulating extracardiac blood supply, and the cell technologies used in patients with coronary artery disease. Particular attention is paid to the development of a surgical and biotechnological technique called «YurLeon», developed by academician Y.L. Shevchenko. Early intervention methods have become relevant due to the rapid development of cellular technologies, allowing for significant improvement and expansion of methods for stimulating vasculogenesis.
Keywords: coronary heart disease, extracardiac cardiac revascularization, YurLeon, coronary bypass surgery.
References
1. Zdravookhranenie v Rossii. Moscow: Rosstat; 2023: 179. (In Russ.)
2. Barbarash OL, et al. Clinical practice guidelines for Stable coronary artery disease. Russian Journal of Cardiology. 2020; 25(11): 4076. (In Russ.)
3. De Bruyne B, Pijls NH, Kalesan B, et al. FAME 2 Trial Investigators. Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. N Engl J Med 2012; 367:991–1001.
4. Fearon WF, Nishi T, De Bruyne B, et al. FAME 2 Trial Investigators. Clinical outcomes and costeffectiveness of fractional flow reserve-guided percutaneous coronary intervention in patients with stable coronary artery disease: Three-year follow-up of the FAME 2 trial (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation). Circulation. 2018; 137: 480-487.
5. Erne P, Schoenenberger AW, Burckhardt D, et al. Effects of percutaneous coronary interventions in silent ischemia after myocardial infarction: The SWISSI II randomized controlled trial. JAMA. 2007; 297: 1985-1991.
6. Thuijs D, et al. Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial. Lancet. 2019. 394(10206): 1325-1334.
7. Farkouh ME, Domanski M, Dangas GD, et al. FREEDOM Follow-On Study Investigators. Long-Term Survival Following Multivessel Revascularization in Patients With Diabetes: The FREEDOM Follow-On Study. J Am Coll Cardiol. 2019; 73(6): 629-638.
8. Belash SA, Barbuhatti KO. Reconstructive surgery for diffuse coronary atherosclerosis without endarterectomy. Innovative medicine of Kuban. 2019; 3(15): 53-61. (In Russ.)
9. Belash SA, et al. Long-term results of myocardial revascularization in combination with endarterectomy in diffuse coronary atherosclerosis. Thoracic and cardiovascular surgery. 2021; 63(3): 188-194. (In Russ.)
10. Kurbanov SK, et al. Hospital and annual results of coronary bypass surgery for diffuse coronary artery disease. Cardiological Bulletin. 2019; 14(1): 60-66. (In Russ.)
11. Shevchenko YuL, Borshchev GG. An integrated approach to myocardial revascularization in patients with coronary artery disease with diffuse coronary lesion using methods of stimulation of extracardial angiogenesis. Modern medicine: new approaches and current research. 2019: 90-98. (In Russ.)
12. Shevchenko YuL, Simonenko VB, Borshchev GG. Extracardial myocardial revascularization in diffuse coronary artery disease as a component of complex treatment of patients with coronary artery disease. Clinical medicine. 2018; 96(11): 10-18. (In Russ.)
13. Akchurin RS, et al. Diffuse coronary artery lesion in coronary surgery (analytical review). Clinical and experimental surgery. 2018; 6(4): 75-81. (In Russ.)
14. Akchurin RS, SHiryaev AA, Petrovich VP, Galyautdinov DM, et al. Sovremennye tendencii v koronarnoj hirurgii. Patologiya krovoobrashcheniya i kardiohir. 2017; 21(3S): 34-44. (In Russ.)
15. Harold JG, Bass TA, Bashore TM, et al. ACCF/AHA/SCAI 2013 update of the clinical competence statement on coronary artery interventional procedures: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and Training (writing committee to revise the 2007 clinical competence statement on cardiac interventional procedures). Circulation. 2013; 128(4): 436-472.
16. Chvokov AV, et al. Bimammarocoronary bypass surgery for diffuse coronary artery disease in patients with coronary artery disease and diabetes mellitus. Bulletin of the National Medical and Surgical Center named after NI Pirogov. 2012; 7(3): 21-23. (In Russ.)
17. Akchurin RS, et al. Coronary bypass surgery for diffuse coronary artery disease: the use of autoarterial transplants. Cardiological Bulletin. 2021; 16(4): 5-10. (In Russ.)
18. Shiryaev AA, et al. Annual results of coronary bypass surgery in patients with diffuse coronary artery disease. Cardiology and cardiovascular surgery. 2021; 14(5): 413-419. (In Russ.)
19. Nishigawa K, Fukui T, Yamazaki M, et al. Ten-Year Experience of Coronary Endarterectomy for the Diffusely Diseased Left Anteri or Descending Artery. Ann Thorac Surg. 2017; 103(3): 710-716.
20. Shapira OM, Akopian G, Hussain A, et al. Improved clinical outcomes in patients undergoing coronary artery bypass grafting with coronary endarterectomy. Ann Thorac Surg. 1999; 68(6): 2273-2278.
21. Hubulava G.G, et al. Features of surgical treatment of recurrent myocardial ischemia in patients after coronary bypass surgery. Bulletin of the I.I. Mechnikov Northwestern State Medical University. 2009; 1(2): 21-28. (In Russ.)
22. Andrievskikh SI, Khubulava GG. Microvascular myocardial dysfunction in patients with coronary heart disease and methods of its correction. Regional blood circulation and microcirculation. 2019; 18(3): 5-8. (In Russ.)
23. Shevchenko YL, Zainiddinov FA, Ulbashev DS. Stimulation of extracardial revascularization during coronary bypass surgery in patients with coronary artery disease with diffuse lesions of the coronary bed. Avicenna’s Bulletin. 2021; 23(3): 462-472. (In Russ.)
24. Thorel CH, et al. Pathologie der Kreislauforgane. Ergebn Allg Pathol Path Anat. 1903; 9: 559.
25. Hudson CL, Moritz AR, Wearn JT. The extracardiac anastomoses of the coronary arteries. The Journal of Experimental Medicine. 1932; 56(6): 919-925.
26. Case RB, Brachfeld N. Surgical therapy of coronary arterial disease with special reference to myocardial revascularization. The American Journal of Cardiology. 1962; 9(3): 425-438.
27. Schildt P, Stanton E, Beck CS. Communications between the coronary arteries produced by the application of inflammatory agents to the surface of the heart. Annals of surgery. 1943; 118(1): 34.
28. Mysh GD, Nepomnyashchikh LM. Myocardial ischemia and cardiac revascularization, 1980. (In Russ.)
29. O’Shaughnessy L. Surgical treatment of cardiac ischemia. Lancet. 1937; 1: 185.
30. Thompson SА. Experiences with cardiopericardiopexy in the treatment of coronary disease. Journal of American Medicine. 1953; 152: 678-681.
31. Thompson SА, Raisbeck MJ. Cardiopericardiopexy; the surgical treatment of coronary arterial disease by the establishment adhesive pericarditis. American International Dud. 1942; 16: 495-520.
32. Ognev BV. Surgical interventions on the pericardium in cardiac asthma. Surgery. 1952; 8. (In Russ.)
33. Nikulin VI. Wide pericardotomy in chronic coronary insufficiency. Symposium on surgical treatment of coronary disease. Moscow, 1962. Р.57-58. (In Russ.)
34. Head SJ, Kieser TM, Falk V, Huysmans HA, Kappetein AP. Coronary artery bypass grafting: part 1 – the evolution over the first 50 years. Eur Heart J. 2013; 34: 2862-2872.
35. O’Shaughnessy L, Slomie D, Watson F. Surgical revascularization of the heart; experimental basis. Lancet. 1939; 1: 617-621.
36. Lezius A. Die kunstliche Blutversorgung des Herzmuskels. Arch Klin Chir. 1937; 189: 342-346.
37. Fieschi D. Criteri anatomo-fisiologici per intervento chirurgico lieve in malati di infartondi cuore e di angina. Arch Ital Chir. 1942; 63: 305-310.
38. Battezzati M, Tagliaferro A, Cattaneo AD. Clinical evaluation of bilateral internal mammary artery ligation as treatment of coronary heart disease. Am J Cardiol. 1959; 4(2): 180-183.
39. Viniberg A. Treatment of coronary artery insuficiency by implantation of the intrnal mammary artery into the ventricular myocardium. J. Thor. Surg. 1952; 23(2): 42-54.
40. Sen PK, Udwadia TE, Kinare SG, Parulkar GB. Transmyocardial acupuncture. J Thorac Cardiovasc Surg. 1950; 50: 181-189.
41. Kononov AYa, Zaitsev VT. Method of treatment of coronary heart disease, 1992. (In Russ.)
42. Beyer M, Beyer U, Mierdl S, Sirch J, von Behren H, Hannekum A. Indirect myocardial revascularization – an experimental study in the dog. Eur J Cardiothorac Surg. 1994; 8(10): 557-562.
43. Beyer M, Kardiol Z. Cardiomyopexy – current status of an indirect revascularization method. German. 1997; 86(1): 125-132.
44. Hughes GC, Biswas SS, Yin B, Baklanov DV, et al. A comparison of mechanical and laser transmyocardial revascularization for induction of angiogenesis and arteriogenesis in chronically ischemic myocardium. J Am Coll Cardiol. 2002; 39(7): 1220-1228.
45. Krämer SC, Görich J, Beyer M, Merkle E, Gerber J, Rilinger N, Sokiranski R, Brambs HJ. CT and arteriography in the evaluation of indirect myocardial revascularization with a free-muscle transplant: initial experience. Radiology. 2000; 216(1): 123-127.
46. Cooke JP, Losordo DW. Modulating the vascular response to limb ischemia: angiogenic and cell therapies. Circ Res. 2015; 116: 1561-1578.
47. Folkman J, Klagsbrun M. Angiogenic factors. Science. 1987; 235: 442-447.
48. Semenza GL. Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1. Annu Rev Cell Dev Biol. 1999; 15: 551-578.
49. Clark RAF. Wound repair: basic biology to tissue engineering In: Principles of Tissue Engineering, edited by Lanza R, Langer R, Vacanti JP. San Diego, CA: Academic Press. 2014. Р.1595-1617.
50. Yanagisawa-Miwa A, Uchida Y, Nakamura F, et al. Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor. Science. 1992; 257: 1401-1403.
51. Uchida Y, Yanagisawa-Miwa A, Nakamura F, Yamada K, Tomaru T, Kimura K, Morita T. Angiogenic therapy of acute myocardial infarction by intrapericardial injection of basic fibroblast growth factor and heparin sulfate: an experimental study. Am Heart J. 1995; 130: 1182-1188.
52. Harada K, Friedman M, Lopez JJ, et al. Vascular endothelial growth factor administration in chronic myocardial ischemia. Am J Physiol. 1996; 270: H1791–H1802.
53. Banai S, Jaklitsch MT, Shou M, et al. Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs. Circulation. 1994; 89: 2183-2189.
54. Lazarous DF, Shou M, Scheinowitz M, Hodge E, et al. Comparative effects of basic fibroblast growth factor and vascular endothelial growth factor on coronary collateral development and the arterial response to injury. Circulation. 1996; 94: 1074-1082.
55. Sakakibara Y, Tambara K, Sakaguchi G, Lu F, et al. Toward surgical angiogenesis using slow-released basic fibroblast growth factor. Eur J Cardiothorac Surg. 2003; 24: 105-111; discussion 112.
56. Goldsmith HS, Griffith AL, Kupferman A, Catsimpoolas N. Lipid angiogenic factor from omentum. JAMA. 1984; 252: 2034-2036.
57. Goldsmith HS, Griffith AL, Catsimpoolas N. Increased vascular perfusion after administration of an omental lipid fraction. Surg Gynecol Obstet. 1986; 162: 579-583.
58. McCluer RH, Evans JE, Williams M, Griffith AL, Catsimpoolas N. Characterization of feline omentum lipids. Lipids. 1987; 22: 229-235.
59. Oyama O, Sugimoto N, Qi X, et al. The lysophospholipid mediator sphingosine-1-phosphate promotes angiogenesis in vivo in ischaemic hindlimbs of mice. Cardiovasc Res. 2008; 78: 301-307.
60. Yau TM, Fung K, Weisel RD, Fujii T, Mickle DAG, Li R-K. Enhanced myocardial angiogenesis by gene transfer with transplanted cells. Circulation. 2001; 104: I-218-I-222.
61. Planat-Benard V, Silvestre J-S, Cousin B, André M, et al. Plasticity of human adipose lineage cells toward endothelial cells: physiological and therapeutic perspectives. Circulation. 2004; 109: 656-663.
62. Cao Y, Sun Z, Liao L, et al. Human adipose tissue-derived stem cells differentiate into endothelial cells in vitro and improve postnatal neovascularization in vivo. Biochem Biophys Res Commun. 2005; 332: 370-379.
63. Miranville A, Heeschen C, Sengenès C, Curat CA, Busse R, Bouloumié A. Improvement of postnatal neovascularization by human adipose tissue-derived stem cells. Circulation. 2004; 110(3): 349-55.
64. Asahara T, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997; 275(5302): 964-966.
65. Shevchenko YL, Borshchev GG, Ulbashev DS. Long-term results of coronary bypass surgery supplemented with surgical stimulation of extracardial myocardial vascularization in patients with diffuse coronary lesion. Complex problems of cardiovascular diseases. 2023; 12(1): 160-171. (In Russ.)
66. Shevchenko YuL, Borshchev GG. Extracardial myocardial revascularization in patients with coronary artery disease with diffuse coronary lesion. M.: Publishing House of NMHC named after N.I. Pirogov, 2022. 292 р. (In Russ.)
67. Shevchenko YL, et al. Investigation of vascular endothelial growth factor in patients with coronary artery disease undergoing coronary artery bypass surgery. Genes and cells. 2019; 14(1): 68-71. (In Russ.)
